{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,15]],"date-time":"2026-08-15T11:27:11Z","timestamp":1786793231664,"version":"build-2736575974"},"reference-count":72,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82172335"],"award-info":[{"award-number":["82172335"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["91846103"],"award-info":[{"award-number":["91846103"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81971994"],"award-info":[{"award-number":["81971994"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82302589"],"award-info":[{"award-number":["82302589"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100022963","name":"Key Research and Development Program of Zhejiang Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100022963","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004731","name":"Natural Science Foundation of Zhejiang Province","doi-asserted-by":"publisher","award":["LQ20H080002"],"award-info":[{"award-number":["LQ20H080002"]}],"id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytokine"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.cyto.2024.156684","type":"journal-article","created":{"date-parts":[[2024,6,26]],"date-time":"2024-06-26T05:11:38Z","timestamp":1719378698000},"page":"156684","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Differential alterations of CXCR3, CXCR5 and CX3CR1 in patients with immune thrombocytopenia"],"prefix":"10.1016","volume":"181","author":[{"given":"Yan","family":"Lv","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Hai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaohua","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhong","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiming","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengjun","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dawei","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4270-671X","authenticated-orcid":false,"given":"Jue","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cyto.2024.156684_b0005","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1056\/NEJMe2110953","article-title":"Immune thrombocytopenia treatment","volume":"385","author":"Bolton-Maggs","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cyto.2024.156684_b0010","doi-asserted-by":"crossref","first-page":"3829","DOI":"10.1182\/bloodadvances.2019000966","article-title":"American Society of Hematology 2019 guidelines for immune thrombocytopenia","volume":"3","author":"Neunert","year":"2019","journal-title":"Blood Adv."},{"key":"10.1016\/j.cyto.2024.156684_b0015","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1080\/13543784.2022.2075340","article-title":"Investigational drugs for immune thrombocytopenia","volume":"31","author":"Provan","year":"2022","journal-title":"Expert Opin. Invest. Drugs"},{"key":"10.1016\/j.cyto.2024.156684_b0020","doi-asserted-by":"crossref","first-page":"3780","DOI":"10.1182\/bloodadvances.2019000812","article-title":"Updated international consensus report on the investigation and management of primary immune thrombocytopenia","volume":"3","author":"Provan","year":"2019","journal-title":"Blood Adv."},{"key":"10.1016\/j.cyto.2024.156684_b0025","doi-asserted-by":"crossref","first-page":"2875","DOI":"10.1182\/blood.2020004858","article-title":"Identification of occult cerebral microbleeds in adults with immune thrombocytopenia","volume":"136","author":"Cooper","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.cyto.2024.156684_b0030","doi-asserted-by":"crossref","first-page":"2829","DOI":"10.1182\/blood-2017-03-754119","article-title":"Clinical updates in adult immune thrombocytopenia","volume":"129","author":"Lambert","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.cyto.2024.156684_b0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2022.101777","article-title":"Efficacy and safety of treatments in newly diagnosed adult primary immune thrombocytopenia: a systematic review and network meta-analysis","volume":"56","author":"Wang","year":"2023","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.cyto.2024.156684_b0040","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1002\/ajh.21107","article-title":"Fatal case of bilateral internal jugular vein thrombosis following IVIg infusion in an adolescent girl treated for ITP","volume":"83","author":"Iroh Tam","year":"2008","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.cyto.2024.156684_b0045","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1111\/jth.12813","article-title":"Severe bleeding events in adults and children with primary immune thrombocytopenia: a systematic review","volume":"13","author":"Neunert","year":"2015","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.cyto.2024.156684_b0050","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1182\/asheducation-2015.1.237","article-title":"Bleeding complications in immune thrombocytopenia","volume":"2015","author":"Arnold","year":"2015","journal-title":"Hematol. Am. Soc. Hematol. Educ. Program"},{"key":"10.1016\/j.cyto.2024.156684_b0055","doi-asserted-by":"crossref","first-page":"3032","DOI":"10.1182\/blood.V95.10.3032","article-title":"Chemokine receptors and their role in inflammation and infectious diseases","volume":"95","author":"Murdoch","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.cyto.2024.156684_b0060","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1189\/jlb.1006645","article-title":"CXCL4-induced migration of activated T lymphocytes is mediated by the chemokine receptor CXCR3","volume":"83","author":"Mueller","year":"2008","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.cyto.2024.156684_b0065","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2019.00379","article-title":"Chemokines and chemokine receptors: new targets for cancer immunotherapy","volume":"10","author":"Mollica Poeta","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cyto.2024.156684_b0070","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/j.tips.2022.09.009","article-title":"Atypical chemokine receptors: emerging therapeutic targets in cancer","volume":"43","author":"Torphy","year":"2022","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.cyto.2024.156684_b0075","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.trecan.2022.04.001","article-title":"Utilizing chemokines in cancer immunotherapy","volume":"8","author":"M\u00e4rkl","year":"2022","journal-title":"Trends Cancer"},{"key":"10.1016\/j.cyto.2024.156684_b0080","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abk1692","article-title":"Multiplexed imaging mass cytometry of the chemokine milieus in melanoma characterizes features of the response to immunotherapy","volume":"7","author":"Hoch","year":"2022","journal-title":"Sci Immunol"},{"key":"10.1016\/j.cyto.2024.156684_b0085","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24010095","article-title":"The anti-inflammatory and immunomodulatory activities of natural products to control autoimmune inflammation","volume":"24","author":"Moudgil","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cyto.2024.156684_b0090","doi-asserted-by":"crossref","first-page":"2775","DOI":"10.4049\/jimmunol.2100082","article-title":"CXCR5+CD8+ T cells: a review of their antibody regulatory functions and clinical correlations","volume":"206","author":"Elzein","year":"2021","journal-title":"J. Immunol."},{"key":"10.1016\/j.cyto.2024.156684_b0095","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1016\/j.immuni.2023.06.025","article-title":"Graded expression of the chemokine receptor CX3CR1 marks differentiation states of human and murine T cells and enables cross-species interpretation","volume":"56","author":"Zwijnenburg","year":"2023","journal-title":"Immunity"},{"key":"10.1016\/j.cyto.2024.156684_b0100","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/cei.13118","article-title":"Diminished CXCR5 expression in peripheral blood of patients with Sjogren's syndrome may relate to both genotype and salivary gland homing","volume":"192","author":"Aqrawi","year":"2018","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.cyto.2024.156684_b0105","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-018-03687-x","article-title":"Directed evolution of broadly crossreactive chemokine-blocking antibodies efficacious in arthritis","volume":"9","author":"Angelini","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.cyto.2024.156684_b0110","doi-asserted-by":"crossref","first-page":"619","DOI":"10.2147\/JIR.S270872","article-title":"Targeting chemokines and chemokine receptors in multiple sclerosis and experimental autoimmune encephalomyelitis","volume":"13","author":"Dhaiban","year":"2020","journal-title":"J. Inflamm. Res."},{"key":"10.1016\/j.cyto.2024.156684_b0115","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.cyto.2019.03.010","article-title":"Inflammatory chemokine profiles and their correlations with effector CD4 T cell and regulatory cell subpopulations in cutaneous lupus erythematosus","volume":"119","author":"M\u00e9ndez-Flores","year":"2019","journal-title":"Cytokine"},{"key":"10.1016\/j.cyto.2024.156684_b0120","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1007\/s00011-023-01731-1","article-title":"CX(3)CR1 modulates SLE-associated glomerulonephritis and cardiovascular disease in MRL\/lpr mice","volume":"72","author":"Cabana-Puig","year":"2023","journal-title":"Inflamm. Res."},{"key":"10.1016\/j.cyto.2024.156684_b0125","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1061939","article-title":"Role of the CXCL13\/CXCR5 axis in autoimmune diseases","volume":"13","author":"Pan","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cyto.2024.156684_b0130","doi-asserted-by":"crossref","first-page":"4087","DOI":"10.1182\/bloodadvances.2020003860","article-title":"Abnormalities of bone marrow B cells and plasma cells in primary immune thrombocytopenia","volume":"5","author":"Yu","year":"2021","journal-title":"Blood Adv."},{"key":"10.1016\/j.cyto.2024.156684_b0135","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1007\/s10875-013-9883-4","article-title":"Characterization of Th1- and Th2-associated chemokine receptor expression in spleens of patients with immune thrombocytopenia","volume":"33","author":"Zhou","year":"2013","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.cyto.2024.156684_b0140","doi-asserted-by":"crossref","first-page":"4770","DOI":"10.7150\/thno.54235","article-title":"Vertebral-specific activation of the CX3CL1\/ICAM-1 signaling network mediates non-small-cell lung cancer spinal metastasis by engaging tumor cell-vertebral bone marrow endothelial cell interactions","volume":"11","author":"Wang","year":"2021","journal-title":"Theranostics"},{"key":"10.1016\/j.cyto.2024.156684_b0145","doi-asserted-by":"crossref","first-page":"11513","DOI":"10.1021\/acs.jmedchem.2c00675","article-title":"Discovery and in vivo evaluation of ACT-660602: a potent and selective antagonist of the chemokine receptor CXCR3 for autoimmune diseases","volume":"65","author":"Meyer","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.cyto.2024.156684_b0150","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aba2502","article-title":"Chemokine receptor CXCR3 is required for lethal brain pathology but not pathogen clearance during cryptococcal meningoencephalitis","volume":"6","author":"Xu","year":"2020","journal-title":"Sci Adv"},{"key":"10.1016\/j.cyto.2024.156684_b0155","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1016\/j.immuni.2023.06.003","article-title":"CXCR3 expression in regulatory T cells drives interactions with type I dendritic cells in tumors to restrict CD8(+) T cell antitumor immunity","volume":"56","author":"Moreno Ayala","year":"2023","journal-title":"Immunity"},{"key":"10.1016\/j.cyto.2024.156684_b0160","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1084\/jem.187.4.655","article-title":"B cell-attracting chemokine 1, a human CXC chemokine expressed in lymphoid tissues, selectively attracts B lymphocytes via BLR1\/CXCR5","volume":"187","author":"Legler","year":"1998","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.cyto.2024.156684_b0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2022.188799","article-title":"CXCL13-CXCR5 axis: regulation in inflammatory diseases and cancer","volume":"1877","author":"Wang","year":"2022","journal-title":"Biochimica et Biophysica Acta (BBA) - Rev Cancer"},{"key":"10.1016\/j.cyto.2024.156684_b0170","doi-asserted-by":"crossref","DOI":"10.1002\/cti2.1450","article-title":"Circulating CXCR5(+) natural killer cells are expanded in patients with myasthenia gravis","volume":"12","author":"Ge","year":"2023","journal-title":"Clin Transl Immunol"},{"key":"10.1016\/j.cyto.2024.156684_b0175","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1038\/nature19317","article-title":"Follicular CXCR5-expressing CD8+ T cells curtail chronic viral infection","volume":"537","author":"He","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.cyto.2024.156684_b0180","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/j.immuni.2016.03.013","article-title":"Gut microbiota drive autoimmune arthritis by promoting differentiation and migration of Peyer's patch T follicular helper cells","volume":"44","author":"Teng","year":"2016","journal-title":"Immunity"},{"key":"10.1016\/j.cyto.2024.156684_b0185","doi-asserted-by":"crossref","first-page":"5021","DOI":"10.1182\/blood-2012-04-424648","article-title":"Splenic proliferative lymphoid nodules distinct from germinal centers are sites of autoantigen stimulation in immune thrombocytopenia","volume":"120","author":"Daridon","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.cyto.2024.156684_b0190","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.cell.2021.01.002","article-title":"Meta-analysis of tumor- and T cell-intrinsic mechanisms of sensitization to checkpoint inhibition","volume":"184","author":"Litchfield","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.cyto.2024.156684_b0195","article-title":"HIV infection","volume":"9","author":"Bekker","year":"2023","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.cyto.2024.156684_b0200","doi-asserted-by":"crossref","DOI":"10.1186\/s12974-020-01847-9","article-title":"Repopulation of T, B, and NK cells following alemtuzumab treatment in relapsing-remitting multiple sclerosis","volume":"17","author":"Gilmore","year":"2020","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.cyto.2024.156684_b0205","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/nature16939","article-title":"Effector T-cell trafficking between the leptomeninges and the cerebrospinal fluid","volume":"530","author":"Schl\u00e4ger","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.cyto.2024.156684_b0210","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1100869","article-title":"Chemokines and chemokine receptors as promising targets in rheumatoid arthritis","volume":"14","author":"Murayama","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cyto.2024.156684_b0215","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1002\/eji.201646387","article-title":"Mapping urinary chemokines in human lupus nephritis: potentially redundant pathways recruit CD4(+) and CD8(+) T cells and macrophages","volume":"47","author":"Klocke","year":"2017","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.cyto.2024.156684_b0220","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1161\/ATVBAHA.111.237412","article-title":"Fractalkine: a survivor's guide: chemokines as antiapoptotic mediators","volume":"32","author":"White","year":"2012","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.cyto.2024.156684_b0225","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-021-21619-0","article-title":"T-cell CX3CR1 expression as a dynamic blood-based biomarker of response to immune checkpoint inhibitors","volume":"12","author":"Yamauchi","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.cyto.2024.156684_b0230","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1038\/s41590-019-0398-x","article-title":"The immune cell landscape in kidneys of patients with lupus nephritis","volume":"20","author":"Arazi","year":"2019","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.cyto.2024.156684_b0235","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.664202","article-title":"Fractalkine (CX3CL1) and its receptor CX3CR1: a promising therapeutic target in chronic kidney disease?","volume":"12","author":"Cormican","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cyto.2024.156684_b0240","doi-asserted-by":"crossref","first-page":"2944","DOI":"10.1111\/febs.14466","article-title":"A guide to chemokines and their receptors","volume":"285","author":"Hughes","year":"2018","journal-title":"FEBS J."},{"key":"10.1016\/j.cyto.2024.156684_b0245","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.thromres.2019.02.020","article-title":"Aberrant expression of NLRP3, NLRC4 and NLRP6 inflammasomes in patients with primary immune thrombocytopenia","volume":"176","author":"Lv","year":"2019","journal-title":"Thromb. Res."},{"key":"10.1016\/j.cyto.2024.156684_b0250","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.3324\/haematol.2018.204446","article-title":"All-trans retinoic acid protects mesenchymal stem cells from immune thrombocytopenia by regulating the complement\u2013interleukin-1\u03b2 loop","volume":"104","author":"Zhu","year":"2019","journal-title":"Haematologica"},{"key":"10.1016\/j.cyto.2024.156684_b0255","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1182\/blood.2020008477","article-title":"Low-dose decitabine modulates T-cell homeostasis and restores immune tolerance in immune thrombocytopenia","volume":"138","author":"Han","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.cyto.2024.156684_b0260","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2017.09.013","article-title":"Platelet-derived chemokines in inflammation and atherosclerosis","volume":"122","author":"Bakogiannis","year":"2019","journal-title":"Cytokine"},{"key":"10.1016\/j.cyto.2024.156684_b0265","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/s41577-023-00834-4","article-title":"The role of platelets in immune-mediated inflammatory diseases","volume":"23","author":"Scherlinger","year":"2023","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.cyto.2024.156684_b0270","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-019-09683-z","article-title":"CXCL4 assembles DNA into liquid crystalline complexes to amplify TLR9-mediated interferon-\u03b1 production in systemic sclerosis","volume":"10","author":"Lande","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.cyto.2024.156684_b0275","article-title":"CXCL4 synergizes with TLR8 for TBK1-IRF5 activation, epigenomic remodeling and inflammatory response in human monocytes","volume":"13","author":"Yang","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.cyto.2024.156684_b0280","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1182\/blood-2007-01-067116","article-title":"Platelet factor 4 is a negative autocrine in vivo regulator of megakaryopoiesis: clinical and therapeutic implications","volume":"110","author":"Lambert","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.cyto.2024.156684_b0285","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1038\/s41586-023-06436-3","article-title":"Platelet factors attenuate inflammation and rescue cognition in ageing","volume":"620","author":"Schroer","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.cyto.2024.156684_b0290","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-021-23499-w","article-title":"The C5a\/C5a receptor 1 axis controls tissue neovascularization through CXCL4 release from platelets","volume":"12","author":"Nording","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.cyto.2024.156684_b0295","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-021-27658-x","article-title":"GPR182 limits antitumor immunity via chemokine scavenging in mouse melanoma models","volume":"13","author":"Torphy","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.cyto.2024.156684_b0300","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1182\/blood-2013-05-502807","article-title":"Differences in gene expression and cytokine levels between newly diagnosed and chronic pediatric ITP","volume":"122","author":"Jern\u00e5s","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.cyto.2024.156684_b0305","doi-asserted-by":"crossref","first-page":"589","DOI":"10.3109\/09537104.2014.974526","article-title":"Altered cytokine levels in pediatric ITP","volume":"26","author":"Jern\u00e5s","year":"2015","journal-title":"Platelets"},{"key":"10.1016\/j.cyto.2024.156684_b0310","doi-asserted-by":"crossref","DOI":"10.1186\/s12967-016-1064-9","article-title":"Pulsed high-dose dexamethasone modulates Th1-\/Th2-chemokine imbalance in immune thrombocytopenia","volume":"14","author":"Liu","year":"2016","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.cyto.2024.156684_b0315","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.cyto.2017.08.024","article-title":"Increased plasma sCXCL16 levels may have a relationship with Th1\/Th2 imbalance in primary immune thrombocytopenia","volume":"99","author":"Hao","year":"2017","journal-title":"Cytokine"},{"key":"10.1016\/j.cyto.2024.156684_b0320","doi-asserted-by":"crossref","first-page":"937","DOI":"10.2147\/IJGM.S298888","article-title":"Imbalance of T lymphocyte subsets in adult immune thrombocytopenia","volume":"14","author":"Lin","year":"2021","journal-title":"Int J Gen Med"},{"key":"10.1016\/j.cyto.2024.156684_b0325","first-page":"658","article-title":"Abnormal expression of CXCR5(+)CD8(+) T cells and CXCL13 in severe aplastic anemia patients and their correlation with hematological parameters","volume":"103","author":"Qi","year":"2023","journal-title":"Zhonghua Yi Xue Za Zhi"},{"key":"10.1016\/j.cyto.2024.156684_b0330","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1038\/nm921","article-title":"T-cell-mediated cytotoxicity toward platelets in chronic idiopathic thrombocytopenic purpura","volume":"9","author":"Olsson","year":"2003","journal-title":"Nat. Med."},{"key":"10.1016\/j.cyto.2024.156684_b0335","article-title":"Intratumoral CXCR5+CD8+T associates with favorable clinical outcomes and immunogenic contexture in gastric cancer","volume":"12","author":"Wang","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.cyto.2024.156684_b0340","doi-asserted-by":"crossref","DOI":"10.1126\/science.abd5926","article-title":"Reversible CD8 T cell\u2013neuron cross-talk causes aging-dependent neuronal regenerative decline","volume":"376","author":"Zhou","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.cyto.2024.156684_b0345","first-page":"2417","article-title":"The role of CD8+ T-cell clones in immune thrombocytopenia","volume":"141","author":"Malik","year":"2023","journal-title":"Blood Adv."},{"key":"10.1016\/j.cyto.2024.156684_b0350","doi-asserted-by":"crossref","first-page":"R580","DOI":"10.1152\/ajpregu.00240.2012","article-title":"CCL2 and CCL3 are essential mediators of pelvic pain in experimental autoimmune prostatitis","volume":"303","author":"Quick","year":"2012","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"10.1016\/j.cyto.2024.156684_b0355","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2021-003131","article-title":"CCR1 and CCR5 mediate cancer-induced myelopoiesis and differentiation of myeloid cells in the tumor","volume":"10","author":"Zilio","year":"2022","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.cyto.2024.156684_b0360","article-title":"Novel therapeutic targeting of CCL3-CCR4 axis mediated apoptotic intesitnal injury in necrotizing enterocolitis","volume":"13","author":"Yuan","year":"2022","journal-title":"Front. Immunol."}],"container-title":["Cytokine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S104346662400187X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S104346662400187X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,15]],"date-time":"2026-08-15T11:16:06Z","timestamp":1786792566000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S104346662400187X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":72,"alternative-id":["S104346662400187X"],"URL":"https:\/\/doi.org\/10.1016\/j.cyto.2024.156684","relation":{},"ISSN":["1043-4666"],"issn-type":[{"value":"1043-4666","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Differential alterations of CXCR3, CXCR5 and CX3CR1 in patients with immune thrombocytopenia","name":"articletitle","label":"Article Title"},{"value":"Cytokine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cyto.2024.156684","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"156684"}}